Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review

Immun Inflamm Dis. 2021 Mar;9(1):3-7. doi: 10.1002/iid3.384. Epub 2021 Jan 12.

Authors

Sara Manti¹, Giuseppe Fabio Parisi¹, Maria Papale¹, Gian Luigi Marseglia², Amelia Licari², Salvatore Leonardi¹

Affiliations

¹ Pediatric Respiratory Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
² Department of Pediatrics, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

No abstract available

Publication types

Review

MeSH terms

Conjunctivitis, Allergic* / drug therapy
Humans
Omalizumab* / therapeutic use
Treatment Outcome

Substances

Omalizumab